VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NVCT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NVCTNuvectis Pharma, Inc.
$19.20$509M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksNVCTQuarterly Financials

Nuvectis Pharma, Inc. (NVCT) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Nuvectis Pharma, Inc. (NVCT) quarterly income statement — complete revenue, gross profit & net income history

NVCT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold00000000000000000000
COGS % of Revenue--------------------
Gross Profit00000000000000000000
Gross Margin %--------------------
Gross Profit Growth %--------------------
Operating Expenses6.26M7.62M7.79M6.59M5.57M6.45M4.36M4.64M4.4M6.87M6.16M5.77M4.1M6.78M5.94M3.57M2.94M2.27M4.67M5.94M
OpEx % of Revenue--------------------
Selling, General & Admin2.15M2.53M2.02M2.98M1.89M1.95M1.54M1.7M1.74M2.6M1.67M1.51M1.73M2.38M1.42M1.07M1.14M1.12M512K1.69M
SG&A % of Revenue--------------------
Research & Development4.11M5.09M5.77M3.61M3.68M4.5M2.82M2.94M2.66M4.26M4.49M4.26M2.37M4.4M4.52M2.5M1.8M1.14M4.16M4.25M
R&D % of Revenue--------------------
Other Operating Expenses00000000000000000000
Operating Income-6.26M-7.62M-7.79M-6.59M-5.57M-6.45M-4.36M-4.64M-4.4M-6.87M-6.16M-5.77M-4.1M-6.78M-5.94M-3.57M-2.94M-2.27M-4.67M-5.94M
Operating Margin %--------------------
Operating Income Growth %-12.43%-18.11%-78.8%-42.04%-26.66%6.07%29.21%19.56%-7.19%-1.3%-3.71%-61.54%-39.25%-199.25%-27.21%39.83%-12704.35%---
EBITDA-6.26M-8.21M-7.46M-6.33M-5.57M-6.45M-4.36M-4.64M-4.4M-6.87M-6.16M-5.77M-4.1M-6.78M-5.94M-3.57M-2.94M-2.27M-4.67M-5.94M
EBITDA Margin %--------------------
EBITDA Growth %-12.43%-27.31%-71.19%-36.42%-26.66%6.07%29.21%19.56%-7.19%-1.3%-3.71%-61.54%-39.25%-199.25%-27.21%39.83%-12704.35%---
D&A (Non-Cash Add-back)00000000000000000000
EBIT-6.26M-8.21M-7.46M-6.33M-5.57M-6.45M-4.36M-4.64M-4.4M-6.87M-6.16M-5.77M-4.1M-6.78M-5.94M-3.57M-2.94M-2.27M-4.67M-5.94M
Net Interest Income210K-829K332K261K236K201K206K215K225K244K277K64K52K82K61K4K2K000
Interest Income210K-829K332K261K236K201K206K215K225K244K277K64K52K82K61K4K2K000
Interest Expense00000000000000000000
Other Income/Expense210K303K332K261K236K201K206K215K225K244K277K64K52K82K61K4K2K4K00
Pretax Income-6.05M-7.31M-7.46M-6.33M-5.33M-6.25M-4.15M-4.43M-4.17M-6.62M-5.88M-5.71M-4.05M-6.7M-5.88M-3.57M-2.94M-2.26M-4.67M-5.94M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-6.05M-7.31M-7.46M-6.33M-5.33M-6.25M-4.15M-4.43M-4.17M-6.62M-5.88M-5.71M-4.05M-6.7M-5.88M-3.57M-2.94M-2.26M-4.67M-5.94M
Net Margin %--------------------
Net Income Growth %-13.47%-17.06%-79.68%-43.04%-27.84%5.65%29.38%22.42%-3.01%1.11%-0.07%-59.93%-37.58%-196.15%-25.9%39.9%-12695.65%---
Net Income (Continuing)-6.05M-7.31M-7.46M-6.33M-5.33M-6.25M-4.15M-4.43M-4.17M-6.62M-5.88M-5.71M-4.05M-6.7M-5.88M-3.57M-2.94M-2.26M-4.67M-5.94M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.26-0.31-0.44-0.30-0.27-0.34-0.24-0.26-0.25-0.42-0.37-0.38-0.27-0.50-0.42-0.28-0.32-0.21-0.39-0.47
EPS Growth %3.7%8.82%-83.33%-15.38%-8%19.05%35.14%31.58%7.41%16%11.9%-35.71%15.63%-138.1%-7.69%40.43%----
EPS (Basic)-0.26-0.31-0.44-0.30-0.27-0.34-0.24-0.26-0.25-0.42-0.37-0.38-0.27-0.50-0.42-0.28-0.32-0.21-0.39-0.47
Diluted Shares Outstanding23.41M21.81M22.72M21.37M19.94M19.5M17.23M16.9M16.56M17.42M16.1M15.18M14.72M14.64M14.05M12.72M12.72M12.72M12.72M12.72M
Basic Shares Outstanding23.41M21.81M22.72M21.37M19.94M19.5M17.23M16.9M16.56M17.42M16.1M15.18M14.72M14.64M14.05M12.72M12.72M12.72M12.72M12.72M
Dividend Payout Ratio--------------------